Jahrbuch 2006/2007, Teil 1 - Westdeutsches Tumorzentrum Essen

4. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW Jr (1994). Identification of occult micrometastases
in pericolic lymph nodes of Dukes’ B colorectal cancer patients using monoclonal antibodies against
cytokeratin and CC 49. Cancer 73: 563 -569.
5. Heald RJ, Häsband EM, Ryall RD (1982). The mesorectum in rectal cancer surgery – the clue to pelvic recurrence?
Br J Surg 69: 613 - 616.
6. Hermanek P, Hutter RVP, Sobin LH, Wittekind Ch (1999). Classification of isolated tumor cells and micrometastasis.
American Cancer Society 12: 2668 -2673.
7. Herr HW (2003). Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical
cystectomy. Urology 61: 1, 105 -108.
8. Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF (2002). Impact of the number of lymph nodes
retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167: 3, 1295 -1298.
9. Hölzel D, Engel J, Schmidt M, Sauer H (2001). Modell zur primären und sekundären Metastasierung beim Mammakarzinom
und dessen klinische Bedeutung. Strahlenther Onkol 1: 10 -23.
10. Hohenberger W, Meyer Th (2000). Grundzüge der chirurgischen Onkologie. Zbl Chir 125: W39.
11. Hosch StB, Knoefel WT, Metz S, Stoecklein N, Niendorf A, Broelsch ChE et al (1997). Early lymphatic tumor cells
dissemination in pancreatic cancer: frequency and prognostic significance. Pancreas 15: 154 -159.
12. Isaka N, Nozue M, Doy M, Fukao K (1999). Prognostic significance of perirectal lymph node micrometastases in
Dukes B rectal carcinoma: an immunohistochemical study by CAM5.2. Clin Cancer Res 5: 8, 2065 -2068.
13. Izbicki JR, Hosch StB, Pichlmeier U, Rehders A, Busch C, Niendorf A et al (1997). Prognostic value of immunohistochemically
identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer.
N Engl J Med 337: 1188 -1194.
14. Junginger Th, Hossfeld DK, Sauer R (1999). Aktualisierter Konsensus der CAO, AIO und ARO zur adjuvanten Therapie
bei Kolon- und Rektumkarzinom vom 1.7.1998. Dtsch Ärztebl 96: 698 -700.
15. Junginger Th, Kettelhack Ch, Schönfelder M, Saeger HD, Rieske H, Krumenauer F, Hermanke P (2001). Therapeutische
Strategien bei malignen Weichteiltumoren des Erwachsenen. Ergebnisse der Weichteiltumor-Registerstudie
der CAO und Ansatzpunkte für eine Verbesserung der Behandlungsqualität. Chirurg 72: 138 -148.
16. Liefers GJ, Cleton-Jansen AM, von de Velde GJH, Hermans J, van Krieken JHJM, Cornelisse CJ et al (1998). Micrometastasis
and survival in stage II colorectal cancer. N Engl J Med 339: 223 -228.
17. Rosenberg SA, Tepper J, Glatstein E, Costa J, Baker A, Brennan M, DeMoss EV, Seipp C, Sindelar F, Sugarbaker P,
Wesley R (1982). The treatment of soft-tissues sarcomas of the extremities Ann Surg 196: 305 -315.
18. Stein JP, Cai J, Groshen S, Skinner DG (2003). Risk factors for patients with pelvic lymph node metastases following
radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol 170: 1, 35 - 41.
19. Taat CW, van Lanschot JB, Gouma DJ, Obertop H (1995). Role of extended lymph node dissection in the treatment of
gastrointestinal tumours: A review of the literature. Scand J Gastroenterol 212: 109 -116.
20. Tsioulias GJ, Wood ThF, Morton DL, Bildnik AJ (2000). Lymphatic mapping and focused analysis of sentinel lymph
nodes upstage gastrointestinal neoplasms. Arch Surg 135: 926 - 932.
21. Wawroschek F, Vogt H, Weckermann D, Wagner T, Hamm M, Harzmann R (2001). Radioisotope guided pelvic lymph
node dissection for prostate cancer. J Urol 166: 1715 -1719.
22. Weitz J, Kienle P, Magener A, Koch M, Schrodel A, Willeke F, Autschbach F, Lacroix J, Lehnert T, Herfarth C, von
Knebel, Doeberitz M (1999). Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone
marrow. Clin Cancer Res 5: 7, 1830 -1836.
33